Inspire Medical Systems, Inc. (INSP)

Import this data to Google Sheets with:

=jivedata("INSP","financials")

Full statements spill as a table. For one cell: =jivedata("INSP","Revenue") or =jivedata("INSP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Inspire Medical Systems, Inc.

INSP • CIK 0001609550

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$185,537	$150,150	$104,813	$127,761
Short-term Investments	$274,838	$295,396	$203,455	$192,923
Assets, Current	$593,739	$630,806	$583,652	$608,674
Accounts Receivable, after Allowance for Credit Loss, Current	$89,884	$93,068	$119,692	$103,340
Long-term Investments	$9,143	$70,995	$96,330	$94,480
Inventory, Net	$33,885	$80,118	$145,293	$170,451
Property, Plant and Equipment, Net	$39,984	$71,925	$97,872	$104,330
Prepaid Expense, Current	$9,595	$12,074	$10,399	$14,199
Operating Lease, Right-of-Use Asset	$22,667	$23,314	$23,532	$22,599
Deferred Income Tax Assets, Net	—	—	$88,667	$77,582
Other Assets, Noncurrent	$11,278	$11,343	$17,264	$18,328
Assets	$676,811	$808,383	$907,317	$925,993
Operating Lease, Liability, Noncurrent	$24,846	$30,039	$29,998	$29,093
Other Liabilities, Noncurrent	$1,346	$148	$104	$136
Liabilities	$104,297	$118,688	$126,157	$100,411
Accounts Payable, Trade, Current	$38,839	$38,687	$36,565	$27,102
Accrued Liabilities, Current	$39,266	$49,814	$59,490	$44,080
Liabilities, Current	$78,105	$88,501	$96,055	$71,182
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$30	$30	$29	$29
Additional Paid in Capital	$917,107	$981,043	$927,159	$983,670
Accumulated Other Comprehensive Income (Loss), Net of Tax	$800	$536	$464	$-645
Retained Earnings (Accumulated Deficit)	$-345,423	$-291,914	$-146,492	$-157,472
Stockholders' Equity Attributable to Parent	$572,514	$689,695	$781,160	$825,582
Accounts Receivable, Allowance for Credit Loss, Current	$1,648	$880	$1,080	$997
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	29,560,464	29,740,176	28,579,015	28,907,221

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-21,153	$53,509	$145,422	$135,042
Depreciation, Depletion and Amortization	$2,846	$6,550	$13,957	$17,206
Accretion (Amortization) of Discounts and Premiums, Investments	$2,469	$8,859	$2,889	$1,298
Net Cash Provided by (Used in) Operating Activities	$24,653	$130,246	$116,976	$157,072
Share-based Payment Arrangement, Noncash Expense	$82,470	$116,007	$130,259	$119,394
Deferred Income Taxes and Tax Credits	—	—	$-88,749	$-88,749
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$164	$-118	$-310	$-17
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-256,055	$-35,387	$-45,337	$20,834
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount	$400	$0	$4,046	$0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$185,537	$150,150	$104,813	$149,863
Other Noncash Expense	—	$1,517	$2,111	$1,819
Payments to Acquire Property, Plant, and Equipment	$23,629	$39,123	$38,499	$39,981
Payments to Acquire Debt Securities, Available-for-sale	$281,189	$418,354	$240,318	$213,844
Proceeds from Sale, Maturity and Collection of Investments	$10,246	$344,605	$310,381	$230,161
Payments to Acquire Other Investments	$250	$250	$10,118	$10,118
Net Cash Provided by (Used in) Investing Activities	$-294,822	$-113,122	$21,446	$-31,264
Proceeds from Stock Options Exercised	$25,809	$22,167	$9,595	$1,492
Payments for Repurchase of Common Stock	—	$75,000	$175,019	$100,010
Payment, Tax Withholding, Share-based Payment Arrangement	$17,158	$5,165	$23,044	$10,396
Net Cash Provided by (Used in) Financing Activities	$13,950	$-52,393	$-183,449	$-104,957
Increase (Decrease) in Receivables	$30,218	$2,602	$26,233	$-34,300
Interest Paid, Excluding Capitalized Interest, Operating Activities	$0	$22	$137	$153
Increase (Decrease) in Inventories	$21,999	$46,233	$65,175	$48,819
Capital Expenditures Incurred but Not yet Paid	$4,018	$3,386	$4,773	$1,051
Increase (Decrease) in Prepaid Expense and Other Assets	$4,758	$2,344	$-1,651	$1,777
Increase (Decrease) in Accounts Payable	$9,296	$604	$-3,747	$-22,262
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	$6,898	$12,865	$6,123	$1,205

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("INSP","financials")

Full statements spill as a table. For one cell: =jivedata("INSP","Revenue") or =jivedata("INSP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.